E-LIB Suche - Ergebnisse für: Cavalcante, Ludimila

1

Efficacy and safety of temozolomide-based regimens in advan..:

Taherifard, Erfan ; Bakhtiar, Muhammad ; Mahnoor, Mahnoor...
BMC Cancer. 24 (2024) 1 - p. , 2024

2

EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cel..:

Michelon, Isabella ; Vilbert, Maysa ; do Rego Castro, Caio Ernesto...
Journal of Personalized Medicine. 14 (2024) 7 - p. 752 , 2024

Link: https://doi.org/10.3390/..

3

Pancreatic ductal adenocarcinoma: exploring clinicopatholog..:

Yasinzai, Abdul Qahar Khan ; Tareen, Bisma ; Tracy, Katharine...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

4

Who Should Receive Immunotherapy for Advanced Gastroesophag..:

Khateeb, Suhaib ; Cavalcante, Ludimila ; Alnairat, Noor...
Current Treatment Options in Oncology. 25 (2024) 4 - p. 496-509 , 2024

Link: https://doi.org/10.1007/..

5

Overcoming Immune Checkpoint Therapy Resistance with SHP2 I..:

Tojjari, Alireza ; Saeed, Anwaar ; Sadeghipour, Arezoo..
Cancers. 15 (2023) 22 - p. 5384 , 2023

Link: https://doi.org/10.3390/..

6

SLAM Modification as an Immune-Modulatory Therapeutic Appro..:

Tojjari, Alireza ; Giles, Francis J. ; Vilbert, Maysa..
Cancers. 15 (2023) 19 - p. 4808 , 2023

Link: https://doi.org/10.3390/..

7

A Comprehensive Review on Cancer Vaccines and Vaccine Strat..:

Tojjari, Alireza ; Saeed, Ahmed ; Singh, Meghana...
Vaccines. 11 (2023) 8 - p. 1357 , 2023

Link: https://doi.org/10.3390/..

8

Targeted and Immunotherapy Approaches in HER2-Positive Gast..:

Radford, Maluki ; Abushukair, Hassan ; Hentzen, Stijn..
Journal of Immunotherapy and Precision Oncology. 6 (2023) 3 - p. 150-157 , 2023

Link: https://doi.org/10.36401..

9

Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors..:

Priantti, Jonathan N. ; Vilbert, Maysa ; Madeira, Thiago...
Cancers. 15 (2023) 15 - p. 3754 , 2023

Link: https://doi.org/10.3390/..

10

Characterization of Age-Associated, Neutrophil-to-Lymphocyt..:

Choucair, Khalil ; Nebhan, Caroline ; Cortellini, Alessio...
Cancers. 15 (2023) 20 - p. 5052 , 2023

Link: https://doi.org/10.3390/..

11

Tumor Molecular and Microenvironment Characteristics in EBV..:

Atri-Schuller, Aviva ; Abushukair, Hassan ; Cavalcante, Ludimila...
Current Issues in Molecular Biology. 44 (2022) 11 - p. 5756-5767 , 2022

Link: https://doi.org/10.3390/..

12

Malignant glioma subset from actuate 1801: Phase I/II study..:

Odia, Yazmin ; Cavalcante, Ludimila ; Safran, Howard...
Neuro-Oncology Advances. 4 (2022) 1 - p. , 2022

Link: https://doi.org/10.1093/..

13

Clinical activity of 9-ING-41, a small molecule selective g..:

Hsu, Andrew ; Huntington, Kelsey E. ; De Souza, Andre...
Cancer Biology & Therapy. 23 (2022) 1 - p. 417-423 , 2022

Link: https://doi.org/10.1080/..

14

Elraglusib (9-ING-41), a selective small-molecule inhibitor..:

Shaw, Gary ; Cavalcante, Ludimila ; Giles, Francis J..
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

15

CTNI-13. MALIGNANT GLIOMA SUBSET FROM ACTUATE 1801 PHASE 1/..:

Odia, Yazmin ; Cavalcante, Ludimila ; Safran, Howard...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi61-vi62 , 2021

Link: https://doi.org/10.1093/..